High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer

Breast Cancer Research

Volumn 8, Issue 4, 2006, Pages

  Rennstam, Karin ^a   Hedenfalk, Ingrid ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST EPITHELIUM; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; DNA MICROARRAY; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; GENE MUTATION; GENE TECHNOLOGY; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; METASTASIS; MOLECULAR DYNAMICS; PRECANCER; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; TUMOR CELL; BREAST; BREAST TUMOR; CELL TRANSFORMATION; DISEASE COURSE; EPITHELIUM; FEMALE; GENETIC PROCEDURES; GENETICS; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; PAGET NIPPLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RESEARCH;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENETIC TECHNIQUES; HUMANS; NEOPLASM METASTASIS; PRECANCEROUS CONDITIONS; RESEARCH;

EID: 33846896651     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1528     Document Type: Review

References (30)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70.
2. Allred DC, Mohsin SK, Fuqua SA: Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001, 8:47-61.
3. Ellis IO, Schnitl SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, Eusebi V, Peterse JL, Mukai K, Tabár L, Jacquemier J, et al.: Tumours of the breast. In Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Edited by Jaffe ES, Stein H, Vardiman JW. Lyon, Francs: IARC Press; 2001:9-110.
4. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR: Molecular evolution of breast cancer. J Pathol 2005, 205:248-254.
5. Behbod F, Rosen JM: Will cancer stem cells provide new therapeutic targets? Carcinogenesis 2005, 26:703-711
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective Identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100(7):3983-3988.
7. Eltoum IA, Siegal GP, Frost AR: Microdissection of histologic sections: past, present, and future. Adv Anat Pathol 2002, 9: 316-322.
8. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S. Watson PH, Eng C: Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: Clues to tumour-microenvironment interactions. Hum Mol Genet 2001, 10:1907-1913.
9. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C: Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002, 32:355-357.
10. Ding L, Erdmann C, Chinnaiyan AM, Merajver SD, Kleer CG: Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res 2006, 66:4095-4099.
11. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, et al.: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
12. Velculescu VE, Zhang L, Vogelslein B, Kinzler KW: Serial analysis of gene expression. Science 1995, 270:484-487.
13. Ishii M, Hashimoto S, Tsutsumi S, Wada Y, Matsushima K, Kodama T, Aburatani H: Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics 2000, 68:136-143.
14. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-46.
15. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, et al.: A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004, 36:299-303.
16. Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J et al.: Representational oligonucleotide microarrary analysis: A high-resolution method to detect genome copy number variation. Genome Res 2003, 13:2291-2305.
17. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci USA 2001, 98:10869-10874.
18. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, et al.: Gene-expression profiles in hereditary breast cancer. N Engl J Md 2001, 344:539-548.
19. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003, 100: 8418-8423.
20. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, et al.: Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 2003, 100:2532-2537.
21. Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM: Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res 2004, 6:R499-R513.
22. Mimori K, Kataoka A, Yoshinaga K, Ohta M, Sagara Y, Yoshikawa Y, Ohno S, Barnard GF, Mori M: Identification of molecular markers for metastasis-related genes in primary breast cancer cells, Clin Exp Metastasis 2005, 22:59-67.
23. Ma XJ, Salunga R, Tuggle JT, Gaudel J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, et al.: Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003, 100:5974-5979.
24. Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van't Veer LJ: Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 2005, 65:9155-9158.
25. Brenton JD, Carey LA, Ahmed AA, Caldas C: Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? J Clin Oncol 2005, 23:7350-7360.
26. Lukas J, Niu N, Press MF: P53 mutations and expression in breast carcinoma in situ. Am J Pathol 2000, 156:183-191.
27. Slark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton LI, 3rd, Liu ET, Conway K: HER-2/neu amplification In benign breast disease and the risk of subsequent breast cancer. J Clin Oncol 2000, 18:267-274.
28. Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, Brennan C, Polyak K: Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006, 66: 4065-4078.
29. Kononen J, Bubendori L, Kallioniemi A. Barlund M, Schrami P, Leighton S, Torhorst J, Mihatsch MJ, Saular G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
30. Yen PS, Chinnambally V, Ibrahim A, Liu JC, Diaz N, Centeno B, Weber F, Leu YH, Eng C, Yeatman TJ, et al.: Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue [abstract]. In Proceedings of AACR 97th Annual Meeting; 1-5 April 2006, Washington, DC. Philadelphia: American Association for Cancer Research; 2006.